{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-006051","form_type":"8-K","ticker":"GWLL","cik":"0001800373","company_name":"GOLDENWELL BIOTECH, INC.","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.029463+00:00","generated_at":"2026-05-17T11:31:06.300423+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Goldenwell Biotech's auditor KCCW resigns; Michael Gillespie & Associates appointed","bullets":["KCCW resigned as independent registered public accounting firm on July 24, 2025, with no disagreements on accounting principles.","KCCW's reports for 2023 and 2024 included a going concern qualification about the company's ability to continue.","Board appointed Michael Gillespie & Associates as the new auditor on August 14, 2025; it previously served from Nov 2024 to Jan 2025.","No reportable events or disagreements occurred with either former or new auditor."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-006051","json":"https://secwatch.observer/filing/0001477932-25-006051.json","markdown":"https://secwatch.observer/filing/0001477932-25-006051.md","text":"https://secwatch.observer/filing/0001477932-25-006051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/0001477932-25-006051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/gdwl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:31:06.300423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3d52ec32df78c9f72d954de8c87ce250a69a3c7a","claim":"GOLDENWELL BIOTECH, INC. engaged Michael Gillespie & Associates, PLLC as its auditor.","evidence_excerpt":"On August 14, 2025, the board of directors of the Company resolved to engage the independent registered public accounting firm Michael Gillespie & Associates, PLLC (“Michael Gillespie & Associates”), as the Company’s new independent registered public accountants, which appointment Michael Gillespie & Associates has accepted.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/0001477932-25-006051-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Michael Gillespie & Associates, PLLC"}],"fact_type":"auditor_change"},{"claim_id":"900501e64be3f57edd954c929a0a54e9a2fca1fb","claim":"KCCW Accountancy Corp. resigned as auditor of GOLDENWELL BIOTECH, INC..","evidence_excerpt":"On July 24, 2025, KCCW Accountancy Corp. (“KCCW”) notified Goldenwell Biotech, Inc. (the “Company”) it had resigned as the independent registered public accounting firm of the Company.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/0001477932-25-006051-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"KCCW Accountancy Corp."}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}